A synthetic hexapeptide (Argireline) with antiwrinkle activity

Summary

This study characterized the mechanism of action of acetyl hexapeptide-3 (Argireline), the parent compound of SNAP-8 (acetyl octapeptide-3), which inhibits SNARE complex formation to reduce neurotransmitter release at neuromuscular junctions. The peptide demonstrated dose-dependent inhibition of catecholamine release from chromaffin cells and reduced wrinkle depth in clinical assessments, establishing the botulinum toxin-like mechanism of this class of cosmetic peptides.

Key Findings

• Acetyl hexapeptide-3 inhibited SNARE complex assembly by competing with SNAP-25 for binding to syntaxin and synaptobrevin, reducing vesicular exocytosis
• Dose-dependent inhibition of catecholamine release (up to 40% reduction) was demonstrated in chromaffin cell assays at micromolar concentrations
• Clinical evaluation in 10 volunteers showed a mean 30% reduction in periorbital wrinkle depth after 30 days of topical application, as measured by silicone replica analysis